119 related articles for article (PubMed ID: 16625725)
1. Extended abstracts of the annual meeting of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR), Vienna, Austria, 2005.
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):566-608. PubMed ID: 16625725
[No Abstract] [Full Text] [Related]
2. Extended abstracts of the Annual Symposium of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR). June 12-14, 2008. Göttingen, Germany.
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-64. PubMed ID: 19385009
[No Abstract] [Full Text] [Related]
3. The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.
Müller HJ; Grubert M; Hilger R; Richly H; Port R; Scheulen M; Mross K;
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):575-7. PubMed ID: 12503820
[No Abstract] [Full Text] [Related]
4. 2004 Annual Spring Meeting of the Austrian Society of Hematology and Oncology. 15-17 April 2004, Vienna, Austria. Abstracts.
Acta Med Austriaca Suppl; 2004; 63():1-31. PubMed ID: 15202438
[No Abstract] [Full Text] [Related]
5. 10 Years CESAR Anticancer Drug Research - The 7th CESAR Annual Meeting 2009. Preface.
Edler L; Sehrt D; Scheulen ME
Int J Clin Pharmacol Ther; 2010 Jul; 48(7):435-9. PubMed ID: 20557836
[No Abstract] [Full Text] [Related]
6. Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
Ritter C; Sehrt D; Jaehde U
Int J Clin Pharmacol Ther; 2012 Jan; 50(1):53-4. PubMed ID: 22192647
[No Abstract] [Full Text] [Related]
7. [Abstracts of the Annual Meeting of the Austrian Society of Hematology and Oncology, 12-14 April 2007, Vienna, Austria].
Wien Med Wochenschr Suppl; 2007; 157(121):1-38. PubMed ID: 17484065
[No Abstract] [Full Text] [Related]
8. Proceedings of the 16th Meeting of the Working Group for Pharmacology in Oncology and Hematology. Munster, Germany, June 21-22, 2002.
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):560-88. PubMed ID: 12725233
[No Abstract] [Full Text] [Related]
9. European Society for Dermatological Research--34th Annual Meeting. 9-11 September 2004, Vienna, Austria.
Korstanje C
IDrugs; 2004 Nov; 7(11):994-5. PubMed ID: 15551171
[No Abstract] [Full Text] [Related]
10. 15th Annual (ESTRO) European Society for Therapeutic Radiology and Oncology meeting. Vienna, Austria, 23-26 September 1996. Abstracts.
Radiother Oncol; 1996 Sep; 40 Suppl 1():S1-221. PubMed ID: 8952723
[No Abstract] [Full Text] [Related]
11. Annual spring meeting of the Austrian Society of Hematology and Oncology. 23-25 April 1998, Baden, Vienna. Abstracts.
Acta Med Austriaca Suppl; 1998; 46():1-44. PubMed ID: 12508805
[No Abstract] [Full Text] [Related]
12. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
Brockmoeller J; Sehrt D; Scheulen ME
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
[No Abstract] [Full Text] [Related]
13. Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface.
Gastl G; Dittrich C
Onkologie; 2003 Oct; 26 Suppl 6():IX. PubMed ID: 23570176
[No Abstract] [Full Text] [Related]
14. [Munich Hematology Congress. 26th annual meeting of the German Society for Hematology and Oncology, 11-14 October 1981. Abstracts].
Onkologie; 1981 Oct; 4(5):239-87. PubMed ID: 6117044
[No Abstract] [Full Text] [Related]
15. Abstracts of the 10th Meeting of the European Society for Haemapheresis (ESFH) and the 28th Congress of the German Society of Transfusion Medicine and Immuno-Hematology (DGTI). Vienna, Austria, 17-20 September 1995.
Infusionsther Transfusionsmed; 1995 Sep; 22 Suppl 2():1-74. PubMed ID: 15560026
[No Abstract] [Full Text] [Related]
16. Abstracts of the 8th Annual Meeting of the Hematology/Oncology Pharmacy Association. March 21-14, 2012. Orlando, Florida, USA.
J Oncol Pharm Pract; 2012 Mar; 18(1 Suppl):5-22. PubMed ID: 22333736
[No Abstract] [Full Text] [Related]
17. Abstracts of the 9th Annual Meeting of the Hematology/Oncology Pharmacy Association. March 20-23, 2013. Los Angeles, California, USA.
J Oncol Pharm Pract; 2013 Mar; 19(1 Suppl):5-17. PubMed ID: 23444476
[No Abstract] [Full Text] [Related]
18. 2000 Meeting of the Austrian Society for Hematology and Oncology. Vienna, 4-6 May 2000. Abstracts.
Acta Med Austriaca Suppl; 2000; 51():1-48. PubMed ID: 11055229
[No Abstract] [Full Text] [Related]
19. Pharmacology of anticancer drugs.
Oliverio VT
Natl Cancer Inst Monogr; 1977 Mar; (45):57-61. PubMed ID: 927495
[No Abstract] [Full Text] [Related]
20. Abstracts of the Annual Meeting of the Austrian Society of Hematology and Oncology, 27-29 April 2006, Wels, Austria.
Wien Med Wochenschr Suppl; 2006; (118):1-25. PubMed ID: 16886293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
